72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study
- Resource Type
- Article
- Authors
- Boffito, Marta; Clayden, Polly; Peto, Tim; Pozniak, Anton; Taylor, Graham; Kambugu, Andrew; Ayabo, Tabitha; Kitaka, Sabrina Bakeera; Byakika-Kibwika, Pauline; Kiiza, Daniel; Kyohairwe, Isabella; Laker, Eva; Luswata, Andrew; Magoola, Johnson; Mayanja, Hamza; Najujuma, Flavia Vivian; Nakijoba, Ritah; Namuddu, Diana; Namuli, Teopista; Ntuyo, Peter; Onzia, Annet; Sempijja, Emmanuel; Tabwenda, Jovia; William, Baluku; Abrahams, Nina; Magano, Phakamani; Delport, Carmen; Hlwaya, Linda; Mehta, Ushma; Molitsane, Dineo; Odayar, Jasantha; Tambula, Sivuyile; Tyam, Mbuviswa; Venfolo, Olga; Allerton, Joanna; Nkonyana, Thozama; Mqaba, Sibongile; Else, Laura; Potter, Steve; Neary, Anne; Malaba, Thokozile R; Nakatudde, Irene; Kintu, Kenneth; Colbers, Angela; Chen, Tao; Reynolds, Helen; Read, Lucy; Read, Jim; Stemmet, Lee-Ann; Mrubata, Megan; Byrne, Kelly; Seden, Kay; Twimukye, Adelline; Theunissen, Helene; Hodel, Eva Maria; Chiong, Justin; Hu, Nai-Chung; Burger, David; Wang, Duolao; Byamugisha, Josaphat; Alhassan, Yussif; Bokako, Sharon; Waitt, Catriona; Taegtmeyer, Miriam; Orrell, Catherine; Lamorde, Mohammed; Myer, Landon; Khoo, Saye
- Source
- In The Lancet HIV August 2022 9(8):e534-e543
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2352-3018